134 related articles for article (PubMed ID: 12705862)
1. Another tie that binds the MTA family to breast cancer.
Kumar R
Cell; 2003 Apr; 113(2):142-3. PubMed ID: 12705862
[TBL] [Abstract][Full Text] [Related]
2. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer.
Fujita N; Jaye DL; Kajita M; Geigerman C; Moreno CS; Wade PA
Cell; 2003 Apr; 113(2):207-19. PubMed ID: 12705869
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of MTA family members in human cancers.
Kumar R; Wang RA; Bagheri-Yarmand R
Semin Oncol; 2003 Oct; 30(5 Suppl 16):30-7. PubMed ID: 14613024
[TBL] [Abstract][Full Text] [Related]
4. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications.
Toh Y; Nicolson GL
Clin Exp Metastasis; 2009; 26(3):215-27. PubMed ID: 19116762
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells.
Fujita N; Kajita M; Taysavang P; Wade PA
Mol Endocrinol; 2004 Dec; 18(12):2937-49. PubMed ID: 15358836
[TBL] [Abstract][Full Text] [Related]
6. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer.
Fearon ER
Cancer Cell; 2003 Apr; 3(4):307-10. PubMed ID: 12726856
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC; Hsu HM; Chen ST; Hsu GC; Huang CS; Hou MF; Fu YP; Cheng TC; Wu PE; Shen CY
J Biomed Sci; 2006 May; 13(3):419-32. PubMed ID: 16502042
[TBL] [Abstract][Full Text] [Related]
8. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
9. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
10. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation.
Fujita N; Jaye DL; Geigerman C; Akyildiz A; Mooney MR; Boss JM; Wade PA
Cell; 2004 Oct; 119(1):75-86. PubMed ID: 15454082
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor.
Mazumdar A; Wang RA; Mishra SK; Adam L; Bagheri-Yarmand R; Mandal M; Vadlamudi RK; Kumar R
Nat Cell Biol; 2001 Jan; 3(1):30-7. PubMed ID: 11146623
[TBL] [Abstract][Full Text] [Related]
12. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma.
Dong H; Guo H; Xie L; Wang G; Zhong X; Khoury T; Tan D; Zhang H
PLoS One; 2013; 8(5):e62986. PubMed ID: 23671646
[TBL] [Abstract][Full Text] [Related]
13. Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system.
Brüning A; Blankenstein T; Jückstock J; Mylonas I
Cancer Metastasis Rev; 2014 Dec; 33(4):943-51. PubMed ID: 25319202
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors.
Bolós V; Peinado H; Pérez-Moreno MA; Fraga MF; Esteller M; Cano A
J Cell Sci; 2003 Feb; 116(Pt 3):499-511. PubMed ID: 12508111
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
17. Mi-2/NuRD: multiple complexes for many purposes.
Bowen NJ; Fujita N; Kajita M; Wade PA
Biochim Biophys Acta; 2004 Mar; 1677(1-3):52-7. PubMed ID: 15020045
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
19. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER⁺ breast tumors.
Clocchiatti A; Di Giorgio E; Ingrao S; Meyer-Almes FJ; Tripodo C; Brancolini C
FASEB J; 2013 Mar; 27(3):942-54. PubMed ID: 23159930
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.
Dhasarathy A; Kajita M; Wade PA
Mol Endocrinol; 2007 Dec; 21(12):2907-18. PubMed ID: 17761946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
